Generics 285

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Esomeprazole manufacturers

285 products found

Filters

285 products found

esomeprazole

Powder for solution for injection/infusion 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

esomeprazole

Tablets 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Nexium®
Manufacturer #252

Manufacturer usually replies in 2 days

esomeprazole

Powder for solution for injection/infusion 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Ukraine , United Kingdom , Vietnam
Registered in
Portugal
Available for
Licensing with supply, Distribution only
MAs for sale
Germany
Manufacturer #1377
A pharmaceutical manufacturer based in the EU that has been active in 40+ countries selling its products in Europe, the Middle East, North America, Africa, and Asia for 200+ years. Key production lines are Rx, OTC, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. Main dosage forms include solids, liquids, semi-solids, and sterile forms.

Manufacturer usually replies in 8 days

esomeprazole

Capsules 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Nexium®
Manufacturer #252

Manufacturer usually replies in 2 days

esomeprazole

Vials, lyophilized injection 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Iraq , Latvia , Libya , Lithuania , Vietnam
Manufacturer #2346

Manufacturer usually replies in 7 days

esomeprazole

Tablets 20mg, 40mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #623

Manufacturer usually replies in 9 days

esomeprazole

Vials, injection 40mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #623

Manufacturer usually replies in 9 days

esomeprazole

Tablets, modified release (MR) 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Ukraine , Vietnam
Available for
Licensing with supply, Technology transfer
Comments
Ref: Nexium (AstraZeneca)
Manufacturer #263
A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products all over the world for 40+ years. Key production lines are Rx, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. The main dosage form is a solid oral dosage form.

Manufacturer usually replies in 9 days

esomeprazole

Tablets, gastro resistant (GR) 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
MUPS technology This product is registered in European Union
Manufacturer #17047
A pharmaceutical manufacturer based in the EU that sells its products in Europe, the Middle East, CIS, LATAM, and Asia. Key production lines are pharmaceuticals, bio and nanopharmaceuticals, medical devices, and nutraceuticals. The main therapeutic area is oncology.

Manufacturer usually replies in 10 days

esomeprazole

Capsules 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q4 2026
Manufacturer #519

Manufacturer usually replies in 6 days

esomeprazole

Capsules, gastro resistant (GR) 20 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q2 2024 GR mini capsules
Manufacturer #17047
A pharmaceutical manufacturer based in the EU that sells its products in Europe, the Middle East, CIS, LATAM, and Asia. Key production lines are pharmaceuticals, bio and nanopharmaceuticals, medical devices, and nutraceuticals. The main therapeutic area is oncology.

Manufacturer usually replies in 10 days

esomeprazole

Vials, injection 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Saudi Arabia , Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

esomeprazole

Capsules, gastro resistant (GR) 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15084

Manufacturer usually replies in 18 days

esomeprazole

Tablets, gastro resistant (GR) 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #3044

Manufacturer usually replies in nan days

esomeprazole

Tablets 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #30077

Manufacturer usually replies in nan days

esomeprazole + itopride

Tablets 20 mg + 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #30077

Manufacturer usually replies in nan days

esomeprazole

Powder and solvent for solution for injection/infusion 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica , Albania , Bosnia And Herzegovina , Kosovo , Serbia , Slovenia
Registered in
Bulgaria , Turkey
Manufacturer #361

It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

esomeprazole

Capsules 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica , Albania , Bosnia And Herzegovina , Kosovo , Serbia , Slovenia
Registered in
Turkey
Manufacturer #361

It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

esomeprazole

Capsules, enteric coated 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply
Comments
Reference product : Inexium, AstraZeneca
Manufacturer #1304
It has dedicated itself to the development of lifecycle products and has created a wide range of technological platforms for oral delivery, with an emphasis on modified-release formulation and oro-dispersible dosage forms. Using these technologies, the company has created a wide range of medicines in a variety of therapeutic areas, including pain, CNS, cardiology, diabetes, gastrointestinal, and others. The company intends to be a global leader in pharmaceuticals, drug delivery, and innovation.

Manufacturer usually replies in 7 days

esomeprazole

Tablets, orally disintegrating (ODT) 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Israel
GMP approvals
FDA, EU GMP
Unavailable markets
United States
Manufacturer #620
It is focused on the development of novel and proprietary formulations of existing molecules and high-complexity generic formulations. It was founded in the late 1960s. They have a diverse portfolio of more than 85 branded and generic products in more than 175 dosage forms. They have a wide network of more than 30 countries worldwide.

Manufacturer usually replies in 9 days

Want to view all 285 products? Create your free account today!

Esomeprazole Manufacturers

Esomeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). Esomeprazole is used for the management of gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury to the esophagus. This drug is also used for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs. Esomeprazole is prescribed to treat Zollinger-Ellison syndrome, a condition in which the stomach produces excess acid. This medication is also used to relieve symptoms such as difficulty swallowing, persistent cough and other conditions involving excess stomach acid. Manufacturers market Esomeprazole under the Brand name of Nexium. Esomeprazole is available in the dosage form of Tablet (delayed release), Capsule (delayed release), Injection and Oral Suspension. The tablet, capsule and suspension form are administered orally and the injection is administered Intravenously. Esomeprazole injections are supplied as a freeze-dried powder in a single use vial. Esomeprazole is available in 10 mg, 20 mg, 40 mg, 20 mg/5mL and 40 mg/5mL dosage strengths. Esomeprazole should be taken at least one hour before food. Tablets should be swallowed whole, if patients are unable to swallow 40 mg tablet, two 20 mg tablet may be taken, but 40 mg oral suspension should not be divided into two 20 mg dosage for pediatric patients who are unable to take tablet formulation. The usual recommended adult dose for GERD is 40 mg esomeprazole tablet given once a day orally for 8 weeks and 20 mg or 40 mg I.V. injection administered once a day. For Zollinger-Ellison syndrome, the recommended dose is 40 mg tablet orally twice a day and 20 mg or 40 mg I.V. injection administered once a day. Treatment with I.V injection should be discontinued as soon as the patient can resume oral treatment with esomeprazole. The recommended storage conditions for esomeprazole tablets, capsules and I.V. infusion is to store at 25° C (77° F) with excursions permitted to 15° C to 30° C (59° F - 86° F), protect from sunlight. The reconstituted product should not be refrigerated.

Wholesale Price of Esomeprazole

In the USA, the wholesale price of 20 mg esomeprazole oral delayed-release tablets ranges from $ 73.94 - $ 367.74 for a quantity of 90 tablets and the per-unit cost is available at as low as $ 0.81 The per unit cost of 40 mg esomeprazole oral delayed release capsule ranges from $ 0.82 - $3.54 and for a quantity of 90 tablets, the cost ranges from $ 73.94 - $ 318.45 The wholesale price of 40 mg esomeprazole intravenous powder for injection costs around $ 302.66 - $ 429.50 for a quantity of 10 and the per unit cost ranges from $ 30.27 - $ 42.95

Esomeprazole - Mechanism of Action

Esomeprazole suppresses gastric acid secretion by inhibiting the partial cell membrane H+ K+ ATPase enzyme system. This effect leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. The binding to the H+, K+ ATPase results in an inhibition of gastric acid secretion.

Finding Esomeprazole Manufacturers and Suppliers

Finding a faithful partner in our business is one of the massive tests and to overcome that challenge and to make one’s work / life easy in finding the credible manufacturer and supplier of Esomeprazole one can visit the Pipelinepharma website which helps you in finding the dependable manufacturers and suppliers of Esomeprazole. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects proprietor with the consumers for business development. You can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and more.